Qasim Ahmad
Fortuna: 191 $ al 30/06/2026
Fortuna: 191 $ al 30/06/2026
Qasim Ahmad worked at IO Biotech, Inc. as Chief Medical Officer.
Dr. Ahmad worked at Novartis AG as SVP, Head-Clinical Development & Medical Affairs.
Dr. Ahmad graduated from the University of Birmingham, London School of Hygiene & Tropical Medicine, and the University of Surrey.
Dr. Ahmad earned a doctorate from Panjab University Chandigarh.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IO BIOTECH, INC. 0,04 % | 11/04/2025 | 31.350 ( 0,04 % ) | 191 $ | 30/06/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| IO BIOTECH, INC. | Director Técnico/Científico/I+D | 15/02/2026 |
| NOVARTIS AG | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 6 |
|---|---|
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Birmingham
University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London School of Hygiene & Tropical Medicine
London School of Hygiene & Tropical Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Surrey
University of Surrey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Panjab University Chandigarh
Panjab University Chandigarh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IO Biotech, Inc.
IO Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel, immune-modulating cancer therapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.